Thiopurine treatment in patients with Crohn's disease leads to a selective reduction of an effector cytotoxic gene expression signature revealed by whole-genome expression profiling

G. Bouma, J.M. Baggen, A.A. van Bodegraven, C.J.J. Mulder, G. Kraal, A. Zwiers, A.J. Horrevoets, C.T.M. van der Pouw Kraan

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)472-481
JournalMolecular Immunology
Issue number3-4
Publication statusPublished - 2013

Cite this